Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb (BMY) Raises Accelerated Buyback to $7B, to De-Lever Balance Sheet

August 26, 2019 6:37 AM
With Amgen's deal to acquire Celgen's OTEZLA, Bristol-Myers Squibb (NYSE: BMY) announced that it is increasing its previously planned $5 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Buybacks Stock Buybacks

Next Articles